Cherian Kurian Kandathil

Cherian Kurian Kandathil

Auto-generated profile, based on publicly available information

Cherian Kurian Kandathil

Department of Otolaryngology–Head and Neck Surgery, Division of Facial Plastic & Reconstructive Surgery Stanford University School of Medicine Palo Alto California USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2019 in Aesthetic Surgery Journal
Verified
Journal Article
Closed access
PDF file
CKCherian K Kandathil
Cherian K Kandathil
MSMikhail Saltychev
Mikhail Saltychev
MAMohamed Abdelwahab
Mohamed Abdelwahab
ESEmily A Spataro
Emily A Spataro
SMSami P Moubayed
Sami P Moubayed
SMSam P Most
Sam P Most
Background: The minimal clinically important difference (MCID) for the Standardized Cosmesis and Health Nasal Outcomes Survey (SCHNOS) has not been determined. Objectives: The authors sought to define the MCID for both domains of the SCHNOS questionnaire. Methods: This prospective cohort study included patients who underwent functional, cosmetic, or combined rhinoplasty operation from June 2017 to June 2018 at a tertiary referral center. The average preoperative, postoperative, and change in scores were calculated for the nasal obstruction symptom evaluation scale (NOSE) and SCHNOS. Anchor-based MCIDs were estimated for both SCHNOS subscales to define change in obstruction and cosmesis perceived after the rhinoplasty. Results: Eighty-seven patients (69% women, 31% males) with a mean age (standard deviation [SD]) of 38 years (14.7) at the time of surgery were included. The mean postoperative follow-up period (SD) was 145 days (117). The mean preoperative score (SD) for the NOSE was 52 (32), SCHNOS for nasal obstruction (SCHNOS-O) score was 55 (33), and SCHNOS for nasal cosmesis (SCHNOS-C) score was 50 (26) points. Postoperatively, the NOSE score was 23 (22), SCHNOS-O score was 24 (23), and SCHNOS-C score was 13 (18) points. The mean change in scores (SD) for NOSE, SCHNOS-O, and SCHNOS-C was −29 (37), −31 (38), and −37 (28), respectively. The calculated MCID for SCHNOS-O was 26 (16) and for SCHNOS-C was 22 (15) points. The MCID for NOSE was 24 (13) points. A sensitivity test for the patients with a follow-up ≥3 months showed only slightly different MCID estimates: 28 (17) for SCHNOS-O, 18 (13) for SCHNOS-C, and 24 (15) points for NOSE. Conclusions: For the obstruction domain SCHNOS-O, the MCID was 28 points. For the cosmetic domain SCHNOS-C, the MCID was 18 points.

16 September 2024 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
MMMonica K. Rossi Meyer
Monica K. Rossi Meyer
CKCherian Kurian Kandathil
Cherian Kurian Kandathil
SDSeth J. Davis
Seth J. Davis
KDK. Kay Durairaj
K. Kay Durairaj
PPPriyesh N. Patel
Priyesh N. Patel
SMSam P. Most
Sam P. Most

9 January 2020 in Aesthetic Surgery Journal
Verified
Journal Article
Closed access
PDF file
ESEmily A Spataro
Emily A Spataro
CKCherian K Kandathil
Cherian K Kandathil
MSMikhail Saltychev
Mikhail Saltychev
COCristen E Olds
Cristen E Olds
SMSam P Most
Sam P Most
Background: Identifying mental health disorders, including body dysmorphic disorder (BDD), is important prior to rhinoplasty surgery; however, these disorders are underdiagnosed, and screening tools are underutilized in clinical settings. Objectives: The authors sought to evaluate the correlation of a rhinoplasty outcomes tool (Standardized Cosmesis and Health Nasal Outcomes Survey [SCHNOS]) with psychiatric screening tools. Methods: Patients presenting for rhinoplasty consultation were prospectively enrolled and administered mental health instruments to assess depression (Patient Health Questionnaire-9), anxiety (Generalized Anxiety Disorder-7), and BDD (BDD Questionnaire-Aesthetic Surgery [BDDQ-AS]) as well as the SCHNOS rhinoplasty outcomes scale. Convergent validity of SCHNOS scores with these mental health instruments was assessed as well as calculation of an optimal SCHNOS-C score to screen for BDD. Results: A total 76 patients were enrolled in the study. The average SCHNOS-O score (standard deviation) was 46.1 (34.0) and the average SCHNOS-C score was 61.1 (27.0). Five (7%) patients screened positive for depression, and 24 (32%) patients screened positive for mild, 5 (7%) for moderate, and 4 (5%) for severe anxiety. Twenty-four (32%) patients screened positive for BDD by BDDQ-AS scores. SCHNOS-O and SCHNOS-C did not correlate with Patient Health Questionnaire-9 or Generalized Anxiety Disorder-7 scores; SCHNOS-C did correlate with BDDQ-AS. A score of 73 or greater on SCHNOS-C maximized the sensitivity and specificity of also screening positive for BDD with BDDQ-AS. This score correlated with a sensitivity of 62.5%, specificity of 80.8%, and number needed to diagnose of 2.3, meaning for every 2 patients with a score of ≥73 on SCHNOS-C, 1 will have a positive BDDQ-AS score. Conclusions: SCHNOS-C correlates with BDDQ-AS and may help screen rhinoplasty patients at higher risk for BDD. Level of Evidence: 2:

21 July 2020 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
CKCherian K. Kandathil
Cherian K. Kandathil
MSMikhail Saltychev
Mikhail Saltychev
PPPriyesh N. Patel
Priyesh N. Patel
SMSam P. Most
Sam P. Most

21 November 2020 in Aesthetic Surgery Journal
Verified
Journal Article
Closed access
PDF file
ESEmily A Spataro
Emily A Spataro
COCristen E Olds
Cristen E Olds
CKCherian K Kandathil
Cherian K Kandathil
SMSam P Most
Sam P Most
Background: Psychiatric comorbidity is associated with greater 30-day postoperative complication rates in various surgical specialties, but is not well characterized for reconstructive plastic surgery. Objectives: The aim of this study was to compare reconstructive plastic surgery rates and 30-day postoperative complications between patients with and without psychiatric diagnoses. Methods: This was a retrospective cohort study comparing patients with and without psychiatric diagnoses. Data for January 1, 2007 to December 31, 2015 were collected from the IBM MarketScan Commercial and Medicare Supplemental Databases. Rates of reconstructive plastic surgery, demographic data, covariant diagnoses, and 30-day postoperative complications were collected. Differences between the 2 groups were assessed by multivariable logistic regression. Results: Among 1,019,128 patients (505,715 with psychiatric diagnoses and 513,423 without psychiatric diagnoses) assessed, reconstructive plastic surgery rates were between 4.8% and 7.0% in those with psychiatric diagnoses, compared with 1.6% in patients without psychiatric diagnoses. The greatest odds of undergoing reconstructive plastic surgery were in patients with body dysmorphic disorder (BDD) (adjusted odds ratio [aOR], 3.16; 95% confidence interval [CI], 1.76-5.67) and anxiety disorder (aOR, 3.08; 95% CI, 2.97-3.17). When assessing 1,234,206 patients (613,400 with psychiatric diagnoses and 620,806 without psychiatric diagnoses), all of whom underwent reconstructive plastic surgery, 2-fold greater odds of any 30-day postoperative complication was associated with psychiatric diagnoses (aOR, 2.01; 95% CI, 1.28-3.11), as well as greater odds of specific complications (surgical site infection, bleeding, and hospital admission). Eating disorder diagnosis was associated with the greatest odds of a complication (aOR, 4.17; 95% CI, 3.59-4.86), followed by nasal surgery (aOR, 3.65; 95% CI, 2.74-4.89), and BDD (aOR, 3.16; 95% CI, 1.76-5.67). Conclusions: Diagnosis of a psychiatric condition is associated with greater rates of reconstructive plastic surgery, and 2-fold greater odds of 30-day postoperative complications. Level of Evidence: 4:

1 June 2022 in Facial Plastic Surgery & Aesthetic Medicine
Verified
Journal Article
Closed access
PPPriyesh N. Patel
Priyesh N. Patel
CKCherian K. Kandathil
Cherian K. Kandathil
CBCibele Madsen Buba
Cibele Madsen Buba
JNJosé Carlos Neves
José Carlos Neves
RCRoxana Cobo
Roxana Cobo
SMSam P. Most
Sam P. Most
Background: Dorsal preservation rhinoplasty (DPR) has recently received significant academic attention in part due to theoretical benefits over excisional surgical methods. The purpose of this study was to assess the global practice patterns regarding this technique. Materials and Methods: An 11-item questionnaire was electronically distributed to regional academies/societies representing rhinoplasty surgeons worldwide. Respondent exposure to and use of DPR were assessed based on geographic location. Results: Eight hundred thirty-six responses were received. Despite early publications on DPR originating largely from Western Europe and the United States, Turkey and Mexico have the greatest use of DPR techniques currently. The familiarity across many regions with preservation techniques appear to be secondary to courses and conferences rather than incorporation into training. Mexico demonstrates the greatest exposure to DPR during training. One hundred twenty-five respondents had previously used but abandoned dorsal preservation techniques. Poor results, less predictability, and complications (largely hump recurrence) are cited as common reasons for this. Conclusion: There is variability in the global practice of DPR across regions and this will likely continue to evolve.